Migrasome Therapeutics

Beijing-based biotech startup Migrasome Therapeutics has reported raising upwards of RMB100 million in its angel + funding round. The round was led by ZGC Co-Innovation Fund and included contributions from notable investors such as Tsinghua Capital, Qiangkong Tiancheng Asset Management, BSTIG, and Qihang Investment. Investor Confidence in Migrasome TherapeuticsThe significant…